Everything you need to know about the latest CSL dividend

CSL's latest dividend should be turning investors' heads…

| More on:
Woman with headphones on relaxing and looking at her phone happily.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Yesterday, we got one of the first earnings reports of the season from a major blue chip share. That blue chip share was healthcare stock CSL Ltd (ASX: CSL). We discussed all of the major details at the time, so today, let's dig into the new CSL dividend.

If you missed our initial report, let's quickly go over the highlights in a nutshell.

For the six months to 31 December, CSL reported a 5% rise in revenues (on a constant currency basis) to US$8.48 billion. Net profits after tax were up 7% to US$2.04 billion.

Even so, investors didn't seem to know how to take the results. Upon market open yesterday, CSL shares initially lifted about 1.6%, but finished the day down 4.95% at $256.96 a share.

But let's talk dividends.

The latest CSL dividend

Yesterday, CSL revealed that its next interim dividend would come in at US$1.30 per share. The final amount in Australian dollars has yet to be determined, but the company has told investors to expect around $2.08 per share in the local currency. Like all of the company's payouts last year, this dividend will come unfranked.

This latest payout represents a 9.24% rise on last year's interim dividend of US$1.19 per share.

CSL stock will trade ex-dividend for this payout on 10 March. Investors who have CSL shares to their name at the market close on 9 March can then expect the dividend paycheque to arrive on 9 April.

CSL does technically operate a dividend reinvestment plan (DRP). However, this plan isn't active for this payment, so shareholders have no option other than to receive the dividend in cash.

Together with the final dividend of US$1.45 ($2.17), the latest interim dividend takes CSL's full-year payouts to US$2.75 per share, or $4.38, at current exchange rates.

That gives CSL a forward dividend yield of 1.7% at yesterday's closing price. CSL currently trades on a trailing yield of 1.54%.

CSL share price snapshot

CSL shares have had a rough 12 months, even before yesterday's selloff. As it currently stands, the healthcare giant is nursing an 11.47% loss over the past 12 months. That includes an 8.6% drop in 2025 to date.

The company has still yet to reclaim its pre-COVID 2020 high of over $340 a share.

As it stands today, CSL shares are trading on a market capitalisation of $124.4 billion, with a price-to-earnings (P/E) ratio of 29.65.

Motley Fool contributor Sebastian Bowen has positions in CSL. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL. The Motley Fool Australia has recommended CSL. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

A man has a surprised and relieved expression on his face. as he raises his hands up to his face in response to the high fluctuations in the Galileo share price today
Healthcare Shares

Guess which ASX All Ords stock is rocketing 58% on big US news

What is getting investors excited today? Let's find out.

Read more »

Cropped shot of an attractive young female scientist working on her computer in the laboratory.
Healthcare Shares

3 reasons to buy this quality ASX 200 healthcare share today

A leading expert expects this outperforming ASX 200 healthcare share will keep running hot.

Read more »

A woman reclines in a comfortable chair while she donates blood holding a pumping toy in one hand and giving the thumbs up in the other as she is attached to a medical machine to collect her blood donation.
Healthcare Shares

Brokers tip 4 ASX 200 healthcare shares to buy now

Healthcare is a defensive sector that can provide useful cover for investors when the market is volatile.

Read more »

Shot of a scientist using a computer while conducting research in a laboratory.
Healthcare Shares

How Trump's tariffs have created 'upside potential' for CSL shares

A leading expert says CSL shares are now looking ‘cheap’.

Read more »

Shot of a young scientist looking stressed out while working on a computer in a lab.
Healthcare Shares

Telix shares crash 8% on US FDA blow

This high-flying stock has been hit with some bad news.

Read more »

A man wakes up happy with a smile on his face and arms outstretched.
Healthcare Shares

ResMed shares jump 8% on strong Q3 update

It was yet another strong quarter from this high-quality company.

Read more »

A woman jumps for joy with a rocket drawn on the wall behind her.
Healthcare Shares

Guess which ASX All Ords stock is up 10% on big news

This high-flying stock just can't stop rising. What's going on?

Read more »

Teamwork, planning and meeting with doctors and laptop for medical, review and healthcare. Medicine, technology and internet with group of people for collaboration, diversity and support in hospital
Healthcare Shares

Telix shares rocket 15% on stellar Q1 sales update

Let's see how the company performed during the three months.

Read more »